Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1997 Dec;87(12):1923–1927. doi: 10.2105/ajph.87.12.1923

Leprosy and tuberculosis: the epidemiological consequences of cross-immunity.

T Lietman 1, T Porco 1, S Blower 1
PMCID: PMC1381230  PMID: 9431277

Abstract

OBJECTIVES: This study tested the hypothesis, first proposed by Chaussinand, that individual-level immunity acquired from exposure to tuberculosis may have contributed to the disappearance of leprosy from western Europe. METHODS: The epidemiological consequences of cross-immunity were assessed by the formulation of a mathematical model of the transmission dynamics of tuberculosis and leprosy. RESULTS: The conditions under which Mycobacterium tuberculosis could have eradicated Mycobacterium leprae were derived in terms of the basic reproductive rates of the two infections and the degree of cross-immunity. CONCLUSIONS: If the degree of cross-immunity between two diseases within an individual is known, then the epidemiological consequences of this cross-immunity can be assessed with transmission modeling. The results of this analysis, in combination with previous estimates of the basic reproductive rate of tuberculosis and degree of cross-immunity, imply that tuberculosis could have contributed to the decline of leprosy if the basic reproductive rate of leprosy was low.

Full text

PDF
1923

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel L., Mallet A., Demenais F., Bonney G. E. Modeling the age-of-onset function in segregation analysis: a causal scheme for leprosy. Genet Epidemiol. 1989;6(4):501–516. doi: 10.1002/gepi.1370060405. [DOI] [PubMed] [Google Scholar]
  2. Bates J. H., Stead W. W. The history of tuberculosis as a global epidemic. Med Clin North Am. 1993 Nov;77(6):1205–1217. doi: 10.1016/s0025-7125(16)30188-2. [DOI] [PubMed] [Google Scholar]
  3. Blower S. M., McLean A. R., Porco T. C., Small P. M., Hopewell P. C., Sanchez M. A., Moss A. R. The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med. 1995 Aug;1(8):815–821. doi: 10.1038/nm0895-815. [DOI] [PubMed] [Google Scholar]
  4. Blower S. M., Small P. M., Hopewell P. C. Control strategies for tuberculosis epidemics: new models for old problems. Science. 1996 Jul 26;273(5274):497–500. doi: 10.1126/science.273.5274.497. [DOI] [PubMed] [Google Scholar]
  5. Bremermann H. J., Thieme H. R. A competitive exclusion principle for pathogen virulence. J Math Biol. 1989;27(2):179–190. doi: 10.1007/BF00276102. [DOI] [PubMed] [Google Scholar]
  6. CHAUSSINAND R. Tuberculosis and leprosy; mutually antagonistic diseases. Lepr Rev. 1953 Apr;24(2):90–94. doi: 10.5935/0305-7518.19530009. [DOI] [PubMed] [Google Scholar]
  7. Colditz G. A., Brewer T. F., Berkey C. S., Wilson M. E., Burdick E., Fineberg H. V., Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994 Mar 2;271(9):698–702. [PubMed] [Google Scholar]
  8. Fine P. E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 1995 Nov 18;346(8986):1339–1345. doi: 10.1016/s0140-6736(95)92348-9. [DOI] [PubMed] [Google Scholar]
  9. Fine P. Leprosy and tuberculosis--an epidemiological comparison. Tubercle. 1984 Jun;65(2):137–153. doi: 10.1016/0041-3879(84)90067-9. [DOI] [PubMed] [Google Scholar]
  10. Gupta S., Maiden M. C., Feavers I. M., Nee S., May R. M., Anderson R. M. The maintenance of strain structure in populations of recombining infectious agents. Nat Med. 1996 Apr;2(4):437–442. doi: 10.1038/nm0496-437. [DOI] [PubMed] [Google Scholar]
  11. Gupta S., Swinton J., Anderson R. M. Theoretical studies of the effects of heterogeneity in the parasite population on the transmission dynamics of malaria. Proc Biol Sci. 1994 Jun 22;256(1347):231–238. doi: 10.1098/rspb.1994.0075. [DOI] [PubMed] [Google Scholar]
  12. Lechat M. F. The torments and blessings of the leprosy epidemiometric model. Lepr Rev. 1981 Dec;52 (Suppl 1):187–196. doi: 10.5935/0305-7518.19810069. [DOI] [PubMed] [Google Scholar]
  13. Long E. R. Antagonism among diseases. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):316–319. [PubMed] [Google Scholar]
  14. May R. M., Nowak M. A. Superinfection, metapopulation dynamics, and the evolution of diversity. J Theor Biol. 1994 Sep 7;170(1):95–114. doi: 10.1006/jtbi.1994.1171. [DOI] [PubMed] [Google Scholar]
  15. Orme I. M., Collins F. M. Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria. Infect Immun. 1984 Apr;44(1):28–32. doi: 10.1128/iai.44.1.28-32.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Palmer C. E., Long M. W. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis. 1966 Oct;94(4):553–568. doi: 10.1164/arrd.1966.94.4.553. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES